Cargando…

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke

BACKGROUND AND PURPOSE: Cilostazol, a phosphodiesterase III inhibitor, is known to be a useful antiplatelet agent that inhibits the progression of atherosclerosis in ischemic stroke. This study investigated the effects of combining cilostazol with aspirin on the expressions of P-selectin and PAC-1 o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su-Yun, Kang, Myong-Jin, Cha, Jae-Kwan
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686855/ https://www.ncbi.nlm.nih.gov/pubmed/19513289 http://dx.doi.org/10.3988/jcn.2008.4.4.148

Ejemplares similares

Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
por: Heo, Sung Hyuk, et al.
Publicado: (2012)

Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke
por: Zhang, Wen-hui, et al.
Publicado: (2015)

Surface expression of P-selectin on platelets is related with clinical worsening in acute ischemic stroke.
por: Cha, Jae-Kwan, et al.
Publicado: (2002)

Revision Superficial Temporal Artery-Middle Cerebral Artery Bypass Surgery for Recurrent Acute Ischemic Stroke Due to Delayed Occlusion of the Bypass Graft
por: Choi, Yun-Hee, et al.
Publicado: (2018)

Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial
por: Lim, Jae-Sung, et al.
Publicado: (2021)

Cilostazol minimizes venous ischemic injury in diabetic and normal rats
por: Wajima, Daisuke, et al.
Publicado: (2011)

Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease
por: Lee, Seung-Pyo, et al.
Publicado: (2010)

Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study
por: Ohnuki, Yoichi, et al.
Publicado: (2017)

Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
por: Lee, Tsong-Hai, et al.
Publicado: (2020)

Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions
por: Coenen, Daniëlle M., et al.
Publicado: (2021)

Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke
por: Kim, Yu Ri, et al.
Publicado: (2017)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
por: Galyfos, George, et al.
Publicado: (2017)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Tan, Choon Han, et al.
Publicado: (2021)

Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed Rabbits
por: Ito, Hideki, et al.
Publicado: (2012)

Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model
por: Nagai, Noriaki, et al.
Publicado: (2015)

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
por: Shi, LiGen, et al.
Publicado: (2014)

Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study
por: Senda, Joe, et al.
Publicado: (2019)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
por: Tseng, Kuang-Yi, et al.
Publicado: (2023)

Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation
por: Liu, Hui, et al.
Publicado: (2023)

Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2013)

Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases
por: LIN, GAOPING, et al.
Publicado: (2014)

Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
por: Kim, Kyu Seop, et al.
Publicado: (2011)

Efficacy of Cilostazol on Uncontrolled Coronary Vasospastic Angina: A Pilot Study
por: Yoo, Sang-Yong, et al.
Publicado: (2013)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial
por: Appleton, Jason P., et al.
Publicado: (2019)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
por: McHutchison, Caroline, et al.
Publicado: (2020)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

PAC in FACTT: Time to PAC it in?
por: Mansour, Wissam, et al.
Publicado: (2008)

Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
por: Park, Keun-Ho, et al.
Publicado: (2009)

Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate
por: Seo, Jae Hong, et al.
Publicado: (2015)

Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease
por: Cha, Jung‐Joon, et al.
Publicado: (2023)

Retraction Note: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2015)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Factors Related to Beliefs about Medication in Ischemic Stroke Patients
por: Kim, Gye-Gyoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rfh39ih2pj784jjtsq735t8e5